PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA. (23rd June 2022) - Mingot Castellano, M. E.; Bradbury, C. A.; Rosso Fernández, C.; Thomas, I.; Alvarez-Román, M. T.; Canaro, M.; Caparrós Miranda, I. S.; Cappechi, M.; Carpenedo, M.; Evans, G.; González-Lopéz, J. T.; González-Porras, J. R.; et al.